Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2001, p. 7601-7606, Vol. 21, No. 22
Herman B Wells Center for Pediatric Research,
Section of Pediatric Hematology/Oncology, Department of Pediatrics,
and Department of Biochemistry and Molecular Biology, Indiana
University School of Medicine, Indianapolis, Indiana 46202
Received 31 July 2001/Accepted 28 August 2001
Epigenetic modification of DNA via CpG methylation is essential for
the proper regulation of gene expression during embryonic development.
Methylation of CpG motifs results in gene repression, while CpG
island-containing genes are maintained in an unmethylated state and are
transcriptionally active. The molecular mechanisms involved in
maintaining the hypomethylation of CpG islands remain unclear. The
transcriptional activator CpG binding protein (CGBP) exhibits a unique
binding specificity for DNA elements that contain unmethylated CpG
motifs, which makes it a potential candidate for the regulation of CpG
island-containing genes. In order to assess the global function of this
protein, mice lacking CGBP were generated via homologous recombination.
No viable mutant mice were identified, indicating that CGBP is required
for murine development. Mutant embryos were also absent between 6.5 and
12.5 days postcoitum (dpc). Approximately, one-fourth of all
implantation sites at 6.5 dpc appeared empty with no intact embryos
present. However, histological examination of 6.5-dpc implantation
sites revealed the presence of embryo remnants, indicating that CGBP mutant embryos die very early in development. In vitro blastocyst outgrowth assays revealed that CGBP-null blastocysts are viable and
capable of hatching and forming both an inner cell mass and a
trophectoderm. Therefore, CGBP plays a crucial role in embryo viability
and peri-implantation development.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.22.7601-7606.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
CpG Binding Protein Is Crucial for Early
Embryonic Development
*
Corresponding author. Mailing address: Herman B Wells
Center for Pediatric Research, Cancer Research Building, Room 472, Indiana University School of Medicine, 1044 West Walnut St.,
Indianapolis, IN 46202. Phone: (317) 274-8977. Fax: (317) 274-8928. E-mail: dskalnik{at}iupui.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|